Support 24/7

Email

Telegram

+84 969 116 052

Back
Conotoxia

Conotoxia

Country:
Cyprus
Cyprus
Regulated time: 5 - 10 years
Cyprus https://compassmarkets.com

Score

4.99
Full name
Conotoxia

Instruments
Energy, Stock, Commodities, Metals, Indicies, ETFs, Forex, Futures, CFDs, Cryptocurrencies

Trading platform
MT5, Webtrader

Supervision status
Supervisionstatus

Support email

Hotline
License score
4.00

Risk-control score
4.71

Management score
4.33

Business score
6.00

Software score
9.40
Introduce
License
Complaints

Conotoxia is a Cyprus-based Forex and CFD broker operating under Conotoxia Ltd, authorized and regulated by the Cyprus Securities and Exchange Commission (CySEC) under license number 336/17. The broker is part of the broader Conotoxia Holding Group, known for offering financial services ranging from currency exchange to investment products. It provides access to more than 5,000 trading instruments, including forex pairs, global indices, stocks, commodities, metals, ETFs, cryptocurrencies, futures, and CFDs. Clients can trade through MetaTrader 5 (MT5), cTrader, and a proprietary Webtrader platform. These platforms are equipped with advanced charting tools, algorithmic trading capabilities, and multi-device accessibility. The broker offers different account types to cater to various trading styles, including standard and ECN accounts, with minimum deposits starting from approximately USD 100 or equivalent. For retail clients, leverage is capped at 1:30 under ESMA rules, while professional accounts can access higher leverage. Conotoxia emphasizes transparency in its pricing model. Spreads on standard accounts start from around 0.5 pips for major forex pairs, while raw spread accounts can go as low as 0.1 pips plus a fixed commission. Additional features include negative balance protection, membership in the Investor Compensation Fund (ICF), and multilingual customer support. Funding methods are varied, including bank transfer, credit/debit cards, and e-wallets, with minimal fees. However, in July 2025, CySEC suspended Conotoxia’s authorization due to breaches related to governance, shareholder suitability, and organizational requirements. This suspension temporarily prevents the broker from offering investment services, onboarding new clients, or advertising until compliance issues are resolved. This regulatory action introduces uncertainty for both current and prospective clients. While Conotoxia offers a diverse product range and multiple advanced platforms, the current regulatory suspension is a significant red flag. Traders should monitor the broker’s regulatory status closely before engaging in any trading activities.